Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucie Karayan

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
International Journal of Molecular Sciences|May 14, 2022
The Long Non-Coding RNA <i>HOXA-AS2</i> Promotes Proliferation of Glioma Stem Cells and Modulates Their Inflammation Pathway Mainly through Post-Transcriptional RegulationElisa Le Boiteux, Pierre-Olivier Guichet, Konstantin Masliantsev, et al.
Journal of Neuro-Oncology|October 21, 2009
Prognostic value of O6-methylguanine-DNA methyltransferase status in glioblastoma patients, assessed by five different methodsLucie Karayan-Tapon, Véronique Quillien, Joëlle Guilhot, et al.
Molecular Cancer Therapeutics|July 24, 2014
Selective release of a cyclopamine glucuronide prodrug toward stem-like cancer cell inhibition in glioblastomaAnaïs Balbous, Brigitte Renoux, Ulrich Cortes, et al.
Genome Research|September 20, 2019
Transcriptional alterations in glioma result primarily from DNA methylation-independent mechanismsFranck Court, Elisa Le Boiteux, Anne Fogli, et al.
Plos One|March 21, 2015
IL22/IL-22R pathway induces cell survival in human glioblastoma cellsHussein Akil, Amazigh Abbaci, Fabrice Lalloué, et al.
Plos One|September 19, 2014
DGKI methylation status modulates the prognostic value of MGMT in glioblastoma patients treated with combined radio-chemotherapy with temozolomideAmandine Etcheverry, Marc Aubry, Ahmed Idbaih, et al.
Therapeutic Advances in Gastroenterology|June 23, 2025
Second malignancies in patients with deficient mismatch repair system/microsatellite instability-high colorectal cancerPaul Franques, Pierre Moreau, Camille Evrard, et al.
Cellular and Molecular Gastroenterology and Hepatology|July 23, 2023
Deciphering Brain Metastasis Stem Cell Properties From Colorectal Cancer Highlights Specific Stemness Signature and Shared Molecular FeaturesAmandine Desette, Pierre-Olivier Guichet, Sheik Emambux, et al.
Human Molecular Genetics|March 17, 2022
L1 chimeric transcripts are expressed in healthy brain and their deregulation in glioma follows that of their host locusMarie-Elisa Pinson, Franck Court, Aymeric Masson, et al.
Carcinogenesis|January 1, 2016
The tumoral A genotype of the MGMT rs34180180 single-nucleotide polymorphism in aggressive gliomas is associated with shorter patients' survivalAnne Fogli, Emmanuel Chautard, Catherine Vaurs-Barrière, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
International Journal of Molecular Sciences|May 14, 2022
The Long Non-Coding RNA <i>HOXA-AS2</i> Promotes Proliferation of Glioma Stem Cells and Modulates Their Inflammation Pathway Mainly through Post-Transcriptional RegulationElisa Le Boiteux, Pierre-Olivier Guichet, Konstantin Masliantsev, et al.
Journal of Neuro-Oncology|October 21, 2009
Prognostic value of O6-methylguanine-DNA methyltransferase status in glioblastoma patients, assessed by five different methodsLucie Karayan-Tapon, Véronique Quillien, Joëlle Guilhot, et al.
Molecular Cancer Therapeutics|July 24, 2014
Selective release of a cyclopamine glucuronide prodrug toward stem-like cancer cell inhibition in glioblastomaAnaïs Balbous, Brigitte Renoux, Ulrich Cortes, et al.
Genome Research|September 20, 2019
Transcriptional alterations in glioma result primarily from DNA methylation-independent mechanismsFranck Court, Elisa Le Boiteux, Anne Fogli, et al.
Plos One|March 21, 2015
IL22/IL-22R pathway induces cell survival in human glioblastoma cellsHussein Akil, Amazigh Abbaci, Fabrice Lalloué, et al.
Plos One|September 19, 2014
DGKI methylation status modulates the prognostic value of MGMT in glioblastoma patients treated with combined radio-chemotherapy with temozolomideAmandine Etcheverry, Marc Aubry, Ahmed Idbaih, et al.
Therapeutic Advances in Gastroenterology|June 23, 2025
Second malignancies in patients with deficient mismatch repair system/microsatellite instability-high colorectal cancerPaul Franques, Pierre Moreau, Camille Evrard, et al.
Cellular and Molecular Gastroenterology and Hepatology|July 23, 2023
Deciphering Brain Metastasis Stem Cell Properties From Colorectal Cancer Highlights Specific Stemness Signature and Shared Molecular FeaturesAmandine Desette, Pierre-Olivier Guichet, Sheik Emambux, et al.
Human Molecular Genetics|March 17, 2022
L1 chimeric transcripts are expressed in healthy brain and their deregulation in glioma follows that of their host locusMarie-Elisa Pinson, Franck Court, Aymeric Masson, et al.
Carcinogenesis|January 1, 2016
The tumoral A genotype of the MGMT rs34180180 single-nucleotide polymorphism in aggressive gliomas is associated with shorter patients' survivalAnne Fogli, Emmanuel Chautard, Catherine Vaurs-Barrière, et al.
Pageof 7